Xiangya Hospital Of Central South University
Clinical trials sponsored by Xiangya Hospital Of Central South University, explained in plain language.
-
New eczema drug tested in major Real-World trial
Disease control Not yet recruitingThis study is testing how well an already-approved eczema medication called ivarmacitinib works in everyday practice. It will enroll 1,000 teens and adults with moderate-to-severe atopic dermatitis to measure how quickly itching improves and skin clears up. The research also aims…
Phase: NA • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Double trouble treatment: new combo targets skin and cholesterol together
Disease control Not yet recruitingThis study is testing whether adding a cholesterol-lowering drug (recaticimab) to a standard psoriasis medication (vunakizumab) works better for people who have both conditions. It will involve 40 adults with moderate-to-severe plaque psoriasis and high cholesterol. The main goal…
Phase: PHASE4 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New combo attack on liver Cancer's lung spread
Disease control Not yet recruitingThis study aims to see if a combination of two drugs (camrelizumab and rivoceranib), with or without local treatments like surgery or radiation, can help control advanced liver cancer that has spread to the lungs. It will involve 32 adults who have not had prior treatment for the…
Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Brain-Shield drug added to Clot-Buster in major stroke recovery trial
Disease control Not yet recruitingThis study is testing if adding a brain-protecting drug (butylphthalide) to a standard clot-dissolving medicine (tenecteplase) helps people recover better after a mild but disabling stroke. Over 1,000 participants who have a stroke with mild symptoms but still have trouble with s…
Phase: PHASE3 • Sponsor: Xiangya Hospital of Central South University • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC
-
New blood test aims to spot pancreas infections faster, cut antibiotic overuse
Diagnosis Not yet recruitingThis study aims to develop a faster, more accurate blood test to determine if a patient's severe pancreatitis has become infected. Researchers will test a new method that analyzes genetic material from germs and the body's immune response in a single blood sample from 200 patient…
Sponsor: Xiangya Hospital of Central South University • Aim: Diagnosis
Last updated Apr 03, 2026 14:41 UTC
-
New scan could replace risky brain pressure surgery
Diagnosis Not yet recruitingThis study aims to find a safer way to measure dangerous pressure inside the skull after a head injury. Researchers will test if a simple bedside ultrasound scan on the eye and head is as accurate as the current method, which requires surgery to place a monitor. The goal is to pr…
Sponsor: Xiangya Hospital of Central South University • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC
-
New drug aims to get patients eating and passing gas faster after surgery
Symptom relief Not yet recruitingThis study is testing if a new pain medication called tegileridine helps people's bowels start working again faster after abdominal surgery, compared to the standard drug morphine. About 152 adults having planned abdominal surgery will be randomly assigned to receive one of the t…
Phase: PHASE4 • Sponsor: Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Apr 04, 2026 02:21 UTC
-
Can a common painkiller prevent Post-Surgery confusion in the elderly?
Symptom relief Not yet recruitingThis study aims to see if using a common intravenous pain medication (acetaminophen) is better than a stronger opioid (sufentanil) at preventing confusion and delirium in older patients after non-heart surgery. It will involve over 1,000 patients aged 60+ in intensive care units …
Phase: PHASE4 • Sponsor: Xiangya Hospital of Central South University • Aim: Symptom relief
Last updated Apr 02, 2026 14:56 UTC
-
Massive heart study launches to unravel hidden links between common conditions
Knowledge-focused Not yet recruitingThis large observational study aims to better understand how atrial fibrillation (an irregular heart rhythm) and common metabolic disorders like obesity and diabetes interact in Chinese patients. Researchers will follow 3,459 participants over time to track health outcomes, quali…
Sponsor: Xiangya Hospital of Central South University • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC